Want to see TSE:KETA full AI Analyst Report?
TripSitter Clinic Ltd (KETA) Ratios
TripSitter Clinic Ltd Ratios
TSE:KETA's free cash flow for Q1 2025 was $-24.68K. For the 2025 fiscal year, TSE:KETA's free cash flow was increased by $1.00 and operating cash flow was $-24.68K. See a summary of the company’s cash flow.
| Ratios | Apr 24 | Jan 24 | Jan 23 | Jan 22 | Jan 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.00 | 0.00 | 0.18 | 7.38 | 8.36 |
| Quick Ratio | 0.00 | 0.00 | 0.18 | 7.38 | 8.36 |
| Cash Ratio | 0.00 | 0.00 | 0.10 | 6.57 | 8.27 |
| Solvency Ratio | -0.01 | -0.42 | -2.99 | -212.57 | 0.29 |
| Operating Cash Flow Ratio | -0.06 | 0.00 | 0.00 | 0.00 | 0.00 |
| Short-Term Operating Cash Flow Coverage | -0.14 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -747.37K | $ -727.74K | $ -449.55K | $ 1.26M | $ 687.32K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 283.96 | 96.65 | 1.34 | 0.09 | 0.02 |
| Debt-to-Equity Ratio | -0.45 | -0.38 | -0.30 | 0.11 | 0.03 |
| Debt-to-Capital Ratio | -0.83 | -0.60 | -0.42 | 0.10 | 0.03 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -0.00 | -0.00 | -0.22 | 1.16 | 1.14 |
| Debt Service Coverage Ratio | -0.03 | -1.28 | -13.87 | -1.64 | -9.97 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 1.36 | 0.00 |
| Debt to Market Cap | 1.28 | 1.64 | 0.15 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.05 | 0.04 | 0.02 | 0.53 | 0.00 |
| Net Debt to EBITDA | -35.23 | -0.78 | -0.04 | 0.11 | 4.25 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | -33.65% | 28.41% | -635.85% | 0.00% |
| EBIT Margin | 0.00% | -2493.62% | -381.04% | -2607.52% | 0.00% |
| EBITDA Margin | 0.00% | -2493.62% | -379.34% | -11717.36% | 0.00% |
| Operating Profit Margin | 0.00% | -2493.62% | -379.34% | 24721.98% | 0.00% |
| Pretax Profit Margin | 0.00% | -2181.49% | -382.75% | -11717.35% | 0.00% |
| Net Profit Margin | 0.00% | -2181.49% | -382.75% | -29937.02% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | -2181.49% | -382.75% | -11717.35% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 255.49% | 100.32% |
| EBT Per EBIT | 6.78% | 87.48% | 100.90% | -47.40% | 100.65% |
| Return on Assets (ROA) | -803.18% | -10791.61% | -1882.73% | -1791.76% | -22.97% |
| Return on Equity (ROE) | 1.29% | 41.89% | 415.74% | -2072.80% | -26.09% |
| Return on Capital Employed (ROCE) | 18.95% | 47.89% | 412.03% | 1711.72% | -25.84% |
| Return on Invested Capital (ROIC) | 34.74% | 76.64% | 586.07% | 1711.72% | -25.18% |
| Return on Tangible Assets | -803.18% | -10791.61% | -1882.73% | -1791.76% | -22.97% |
| Earnings Yield | -3.61% | -183.15% | -205.67% | -52.24% | -0.09% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 32.44 | 1.47 | 0.00 |
| Payables Turnover | 0.00 | 0.04 | 0.86 | 3.37 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 4.95 | 4.92 | 0.06 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | -0.02 | 1.21 | 0.09 | 0.00 |
| Cash Conversion Cycle | 0.00 | -8575.14 | -414.80 | 139.67 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 11.25 | 248.13 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 8575.14 | 426.05 | 108.45 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 11.25 | 248.13 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Per Share | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Paid and CapEx Coverage Ratio | -11629.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | -11629.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -0.14 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -17.47% | 0.00% | 0.00% | 0.00% | 0.00% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -28.57 | -0.55 | -0.49 | -1.91 | -1053.96 |
| Price-to-Sales (P/S) Ratio | 0.00 | 11.91 | 1.86 | 573.03 | 0.00 |
| Price-to-Book (P/B) Ratio | -0.36 | -0.23 | -2.02 | 39.68 | 274.99 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -5.73 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Operating Cash Flow Ratio | -5.73 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Earnings Growth (PEG) Ratio | 0.29 | 0.01 | 0.01 | -0.00 | 0.00 |
| Enterprise Value Multiple | -62.96 | -1.25 | -0.53 | -4.78 | -1060.03 |
| Enterprise Value | 604.75K | 436.67K | 987.38K | 48.82M | 188.25M |
| EV to EBITDA | -62.96 | -1.25 | -0.53 | -4.78 | -1060.03 |
| EV to Sales | 0.00 | 31.25 | 2.02 | 559.67 | 0.00 |
| EV to Free Cash Flow | -13.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Operating Cash Flow | -13.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Tangible Book Value Per Share | -0.11 | -0.11 | -0.07 | 0.04 | 0.02 |
| Shareholders’ Equity Per Share | -0.11 | -0.11 | -0.07 | 0.04 | 0.02 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | -1.55 | -0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.08 | 0.00 | 0.00 |
| Net Income Per Share | -0.00 | -0.05 | -0.31 | -0.86 | -0.01 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 2.55 | 1.00 |
| Interest Burden | 1.00 | 0.87 | 1.00 | 4.49 | 0.00 |
| Research & Development to Revenue | 0.00 | 0.22 | 0.59 | 3.28 | 0.00 |
| SG&A to Revenue | 0.00 | 25.27 | 2.72 | 23.94 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 4.84 | 0.00 | 0.00 | 0.00 | 0.00 |
Currency in CAD
